Boeri miRNA signature of risk for lung cancer
miRNA expression analyses in plasma samples collected 1ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å"2 y before the onset of disease, at the time of CT detection and in disease-free smokers enrolled in the screening trial, resulted in the generation of miRNA signatures with strong predictive, diagnostic, and prognostic potential (area under the ROC curve ÃƒÂ¢Ã¢â‚¬Â°Ã‚Â¥ 0.85). The signature of risk for lung cancer is comprised of 16 ratios composed from 15 miRNAs: 140-5p, 660, 320, 28-3p, 451, 92a, 197, 221, 19b, 142-3p, 15b, 30c, 30b, 17, 106a.
No member markers defined for this panel.
There are no datasets associated with this biomarker.